The effect of vitamin E and selenium to reduce the harmful effects of radiation

Assesment of radioprotector effect of Selenium and Vitamin E synergically againt 6Mv X-ray in human blood lymphocyte by micronucli assay.

Status

Active, not recruiting

Phases

Phase 1

Study type

Interventional

Source

IRCT

Registry ID

IRCT2015090123843N1

Enrollment

Registered

2015-10-12

Start date

2013-10-23

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Factors influencing health status and contact with health services. General examination and investigation of persons without complaint and reported diagnosis

Interventions

Intervention 1: Group A: each person will receive 800mg Vitamin E before blood sampling. Intervention 2: Group B: Participants will receive 32mg Selenium before blood sampling. Intervention 3: Group C

Treatment - Other

Treatment - Drugs

Group A: each person will receive 800mg Vitamin E before blood sampling

Group B: Participants will receive 32mg Selenium before blood sampling

Group C: Participants will receive 18 mg selenium and 400 mg vitamin E before blood sampling

Eligibility

Sex/Gender

Male

Age

22 Years to 30 Years

Inclusion criteria

Inclusion criteria: People should be healthy and whitout any disease-specific and non-smokers

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Reduce Chromosomal Damage in Human's Volunteer Blood Lymphocytes. Timepoint: 1 , 2 and 3 Hour after sampling. Method of measurement: Micronucli Assesment.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactAram rostami

Tehran University of Medical Sciences

rostamy_1969@yahoo.com+98 21 8877 6656

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026